Literature DB >> 28893955

NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.

Neekun Sharma1, Camille V Trinidad1, Andrew P Trembath1, Mary A Markiewicz2.   

Abstract

NK group 2 member D (NKG2D) is a strong NK cell-activating receptor, with engagement by ligands triggering granule release and cytokine production. The function of NKG2D signaling in NK cells has largely been studied in the context of engagement of the receptor by ligands expressed on the surface of target cells. We report that upon activation with IL-12, IL-15, and IL-18 human NK cells express NKG2D ligands of the UL16 binding protein family on the cell surface. NKG2D-ligand interaction between cytokine-stimulated NK cells increases the activity of the metalloprotease TNF-α-converting enzyme. This enhanced TNF-α-converting enzyme activity significantly increases the release of TNF-α and UL16 binding protein from the surface of the NK cells. These results demonstrate that NKG2D signaling is critical for maximal TNF-α release by NK cells. Further, they demonstrate a role for NKG2D-ligand interaction via homotypic NK cell contact in NK cell effector function.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28893955      PMCID: PMC5679425          DOI: 10.4049/jimmunol.1700647

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Impairment of NK cell function by NKG2D modulation in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Honor Hsin; Shunsuke Chikuma; Helene Bour-Jordan; Taian Chen; Thomas Pertel; Claude Carnaud; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

2.  Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.

Authors:  David E Oppenheim; Scott J Roberts; Sarah L Clarke; Renata Filler; Julie M Lewis; Robert E Tigelaar; Michael Girardi; Adrian C Hayday
Journal:  Nat Immunol       Date:  2005-08-14       Impact factor: 25.606

Review 3.  Self-tolerance of natural killer cells.

Authors:  David H Raulet; Russell E Vance
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

4.  JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Authors:  Changlin Li; Baoxue Ge; Matthew Nicotra; Joel N H Stern; Hernan D Kopcow; Xi Chen; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 5.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

6.  NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).

Authors:  Rizwan Romee; Bree Foley; Todd Lenvik; Yue Wang; Bin Zhang; Dave Ankarlo; Xianghua Luo; Sarah Cooley; Mike Verneris; Bruce Walcheck; Jeffrey Miller
Journal:  Blood       Date:  2013-03-13       Impact factor: 22.113

7.  Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.

Authors:  Kiva Brennan; Brian P McSharry; Sinéad Keating; Andreea Petrasca; Vincent P O'Reilly; Joseph Keane; Derek G Doherty; Clair M Gardiner
Journal:  Hum Immunol       Date:  2016-06-24       Impact factor: 2.850

Review 8.  TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.

Authors:  Lisa M Sedger; Michael F McDermott
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-01       Impact factor: 7.638

Review 9.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

10.  Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.

Authors:  Louise Bacon; Robert A Eagle; Martina Meyer; Nicholas Easom; Neil T Young; John Trowsdale
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

View more
  9 in total

1.  Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression.

Authors:  Neekun Sharma; Mary A Markiewicz
Journal:  Blood Adv       Date:  2019-05-28

2.  Deficiency of IL12p40 (Interleukin 12 p40) Promotes Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm.

Authors:  Neekun Sharma; Rishabh Dev; Anthony M Belenchia; Annayya R Aroor; Adam Whaley-Connell; Lakshmi Pulakat; Chetan P Hans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 3.  The Paradoxical Role of NKG2D in Cancer Immunity.

Authors:  Sam Sheppard; Amir Ferry; Joana Guedes; Nadia Guerra
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

Review 4.  Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4.

Authors:  Tobias Zöller; Mareike Wittenbrink; Meike Hoffmeister; Alexander Steinle
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

Review 5.  Human NK cells: From development to effector functions.

Authors:  Arosh Shavinda Perera Molligoda Arachchige
Journal:  Innate Immun       Date:  2021-03-24       Impact factor: 2.680

Review 6.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

Review 7.  More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Authors:  Andrew P Trembath; Mary A Markiewicz
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

Review 8.  The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

9.  Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation.

Authors:  Hongxing Wang; Shutong Li; Guoqing Zhang; Hui Wu; Xiaotian Chang
Journal:  Arthritis Res Ther       Date:  2019-10-28       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.